Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Immunomatics raises $100,000 in a strategic investment round led by Myosotis Investments B.V. The funding will accelerate the validation and commercialization of its AI-based donor risk assessment technology.
Amount Raised
$100,000
Round Type
Corporate Round
Investors
Description
Immunomatics, based in San Marcos, California, has secured $100,000 in a strategic investment round. The company is developing AI-driven tools to enhance transplant donor-recipient risk assessment. The funds will be used to accelerate the validation and commercialization of its technology. Myosotis Investments B.V
Fundz sees it the moment Immunomatics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Immunomatics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.